University of the Witwatersrand-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2023

  1. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  2. Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14

  3. Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus

    Antioxidants, Vol. 12, Núm. 8

  4. Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 13, Núm. 8

  5. Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease

    International journal of molecular sciences, Vol. 24, Núm. 6

  6. Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 13, Núm. 1

  7. Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 25, Núm. 1

2022

  1. Apolipoprotein C-III in patients with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 24, Núm. 1

  2. Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 24, Núm. 1

  3. Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus

    Frontiers in Immunology, Vol. 13

  4. Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 12, Núm. 12

2021

  1. Carotid plaque assessment reclassifies patients with inflammatory bowel disease into very-high cardiovascular risk

    Journal of Clinical Medicine, Vol. 10, Núm. 8

  2. Insulin resistance is not increased in inflammatory bowel disease patients but is related to non-alcoholic fatty liver disease

    Journal of Clinical Medicine, Vol. 10, Núm. 14

2020

  1. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study

    Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828

  2. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis

    Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856

2017

  1. HDL cholesterol efflux capacity in rheumatoid arthritis patients: Contributing factors and relationship with subclinical atherosclerosis

    Arthritis Research and Therapy, Vol. 19, Núm. 1

2015

  1. Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 2, pp. 241-249

  2. Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 516-523

2012

  1. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2095-2128